Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 40 clinical trials
  • 0 views
  • 15 Mar, 2022
  • 1 location
A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients

Epirubicin is a common chemotherapy medication used in the treatment of breast cancer. However, chemotherapy dosing is calculated based on people's height and weight, which may not be the most

epirubicin
breast cancer
ejection fraction
immunostimulant
estrogen
  • 0 views
  • 08 Nov, 2020
  • 1 location
Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma

The purpose of this study is to determine determine the maximum tolerated dose (MTD) and safety of the combination of Chidamide combined with CHOEP(cyclophosphamide epirubicin,vindesine

peripheral t-cell lymphoma
etoposide
cyclophosphamide
ct scan
measurable disease
  • 3 views
  • 23 Feb, 2022
  • 2 locations
Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects (CREATE)

Doxorubicin and epirubicin are part of the class of chemotherapy agents called anthracyclines that are commonly used to treat breast cancer. Although these treatments work well against the tumor

breast cancer
anthracyclines
cancer
doxorubicin
breast cancer staging
  • 143 views
  • 04 Oct, 2022
  • 1 location
Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

This is a prospective phase II clinical trial to observe the efficacy and safety of Camrelizumab combined with AVD in the first-line treatment for patients with advanced classical Hodgkin's lymphoma.

vincristine
camrelizumab
epirubicin
dacarbazine
lymphoma
  • 0 views
  • 27 Jan, 2021
  • 1 location
A Phase III, Multicenter, Randomized, Open-Label Study Comparing Atezolizumab (Anti PD-L1 Antibody) in Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone in Patients With Operable Triple Negative Breast Cancer (IMpassion030)

This study will evaluate the efficacy, safety, and pharmacokinetics of adjuvant atezolizumab in combination with paclitaxel, followed by atezolizumab, dose-dense doxorubicin or epirubicin

cancer
taxane
atezolizumab
triple negative breast cancer
anthracyclines
  • 397 views
  • 14 Oct, 2022
  • 411 locations
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer (TCTN)

To compare disease-free survival (DFS) rate of adjuvant chemotherapy epirubicin-cyclophosphamide followed by weekly paclitaxel or docetaxel (EC-T), or weekly paclitaxel or docetaxel-carboplatin

immunohistochemistry
immunostimulant
sentinel node
estrogen
cancer
  • 90 views
  • 24 Apr, 2022
  • 26 locations
Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer (PANSY)

This study is a randomized, single center, phase III clinical trial comparing the efficacy and safety of four cycles of epirubicin combined with cyclophosphamide followed by four cycles of

immunohistochemistry
trastuzumab
immunostimulant
estrogen
progesterone
  • 11 views
  • 20 Feb, 2022
  • 1 location
A Phase II Study of Adjuvant PALbociclib as an Alternative to CHemotherapy in Elderly patientS With High-risk ER+/HER2- Early Breast Cancer (Appalaches)

Phase II study to assess the efficacy of the combination of at least 5 year endocrine therapy and 2 year-palbociclib as adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast cancer.

hormone therapy
estrogen
invasive breast cancer
taxane
bilateral breast cancer
  • 4 views
  • 16 Oct, 2022
  • 77 locations
Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline) (GENSA)

The natural history of non-muscle-invasive bladder cancer is characterised by recurrence and progression. We compare the effectiveness of gemcitabine hydrochloride and epirubicin hydrochloride

transurethral resection
bladder tumor
invasive bladder cancer
gemcitabine
  • 0 views
  • 22 Mar, 2022
  • 1 location